Invention Application
- Patent Title: ACETATE TOXICITY TOLERANCE IN RECOMBINANT MICROBIAL HOST CELLS
-
Application No.: US16648625Application Date: 2018-09-18
-
Publication No.: US20210155944A1Publication Date: 2021-05-27
- Inventor: Brooks Henningsen , Sean Covalla , Rintze Zelle , Allan Froehlich
- Applicant: Lallemand Hungary Liquidity Management LLC
- Applicant Address: HU Budapest
- Assignee: Lallemand Hungary Liquidity Management LLC
- Current Assignee: Lallemand Hungary Liquidity Management LLC
- Current Assignee Address: HU Budapest
- International Application: PCT/IB2018/057187 WO 20180918
- Main IPC: C12N15/81
- IPC: C12N15/81 ; C12N9/92 ; C12N9/12 ; C12N9/90 ; C12N9/10 ; C12N9/04 ; C07K14/395 ; C12N9/00 ; C12P7/06

Abstract:
Acetate is a potent microbial inhibitor which can affect the performance of yeast in ethanolic fermentation. The present disclosure provides a recombinant microbial host cell having (i) a first genetic modification for increasing the activity of one or more proteins that function in a first metabolic pathway to convert acetate into an alcohol in the microbial host cell; (ii) a second genetic modification for increasing the activity of one or more proteins that function in a second metabolic pathway to import glycerol in the recombinant microbial host cell (iii) a third genetic modification for increasing the activity of one or more proteins that function in a third metabolic pathway to convert a C5 carbohydrate into ethanol in the microbial host cell. The recombinant microbial host cell comprises and natively expresses native proteins that function in a fourth native metabolic pathway to produce glycerol in the microbial host cell.
Public/Granted literature
- US11739338B2 Acetate toxicity tolerance in recombinant microbial host cells Public/Granted day:2023-08-29
Information query
IPC分类: